Back
Immunovant, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
37
IMVT
Immunovant, Inc.
Last Price:
$22.86
Seasonality Move:
-10.57%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiImmunovant, Inc. Stock Forecast
-
Over the next 52 weeks, Immunovant, Inc. has on average historically risen by 87.3% based on the past 6 years of stock performance.
-
Immunovant, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Immunovant, Inc. Stock Undervalued?The current Immunovant, Inc. [IMVT] share price is $22.84. The Score for IMVT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
IMVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Immunovant, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Immunovant, Inc. has on average historically risen by 87.3% based on the past 6 years of stock performance.
Immunovant, Inc. Stock Rating
Sell
37
Immunovant, Inc. (IMVT)
is a Sell
Is Immunovant, Inc. overpriced?
-
Immunovant, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Immunovant, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com
52-Week Data
52-Week High:
29.49
52-Week Low:
12.72
Prediction Charts
Market Cap:
4B
Price in USD:
22.84
Volume:
829.6K
Beta:
0.77
Technical Analysis
SMA50:
20.77
SMA100:
18.36
SMA200:
17.43
52-Wk Change:
-19.58%
Stock Predictions
-
Is Immunovant, Inc. stock public?Yes, Immunovant, Inc. is a publicly traded company.
-
What is the Immunovant, Inc. stock quote today?The Immunovant, Inc. stock price is 22.84 USD today.
-
How to buy Immunovant, Inc. stock online?You can buy Immunovant, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 23.84 | 24.30 | 24.73 | 23.50 |
| Nov-18 | 24.30 | 23.69 | 24.30 | 23.39 |
| Nov-19 | 23.69 | 23.16 | 23.90 | 22.99 |
| Nov-20 | 23.62 | 22.79 | 24.06 | 22.75 |
| Nov-21 | 22.20 | 22.59 | 22.85 | 21.86 |
| Nov-24 | 22.53 | 23.32 | 23.45 | 22.43 |
| Nov-25 | 23.32 | 23.95 | 24.07 | 23.00 |
| Nov-26 | 24.00 | 23.70 | 24.01 | 23.39 |
| Nov-28 | 24.00 | 24.15 | 24.42 | 23.80 |
| Dec-1 | 24.11 | 22.75 | 24.14 | 22.73 |
| Dec-2 | 22.90 | 22.02 | 23.06 | 21.93 |
| Dec-3 | 22.22 | 22.71 | 23.06 | 22.10 |
| Dec-4 | 22.55 | 22.91 | 23.31 | 22.29 |
| Dec-5 | 22.89 | 22.84 | 23.12 | 22.58 |
Immunovant, Inc. Earnings
Immunovant, Inc. Earnings Report: Per Share Immunovant, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Immunovant, Inc. Forecast Revenue Growth
Immunovant, Inc. Stock Analysis: Historical quarterly revenues per share for Immunovant, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.13 per share, and a decrease next year of $0.09 per share.
* Immunovant, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.